// App-Quantinova.ai

OC 34.5 : Identification of risk factors for major bleeding during anticoagulation and recurrent venous thromboembolism after its discontinuation in patients with a first unprovoked venous thromboembolism.

Researchers

Presenter

  • C. Gabara

Principal Investigators

  • Y. Yamashita

  • J. Aibar

  • C. Zamora

  • R. Valle

  • L. Mazzolai

  • A. Lorenzo

  • P. Verhamme

  • J. Vela

  • M. Monreal

Medical Centers

  • Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain

  • Kyoto university, Kyoto city, Kyoto, Japan

  • Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain

  • Hospital Sierrallana, Santander, Cantabria, Spain

  • Hôpital de Rangueil, Toulouse, Languedoc-Roussillon, France

  • Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital de Galdakao, Vizcaya, Pais Vasco, Spain

  • Hospital Universitario Infanta Sofia, Madrid, Spain

  • Hospital Universitari Vall dHebron, Barcelona, Spain, Barcelona, Spain

  • Complejo Hospitalario de Jaén, Jaén, Andalucia, Spain

  • Hospital Regional Universitario de Malaga, Malaga, Spain

  • Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KULeuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium

  • Hospital Universitario de Puerto Real, Cadiz, Spain

  • Hospital Universitario de Gran Canaria Dr. Negrín., Las Palmas de Gran Canaria, Spain

  • Hospital Universitario Miguel Servet, Zaragoza, Spain, Zaragoza, Spain

  • Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia, Spain, Barcelona, Andalucia, Spain

Locations

  • Spain

  • Japan

  • France

  • Switzerland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A